Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Journal of the Peripheral Nervous System

Search results

  • RSS Feed
(1 - 7 of 7)
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
Merkies, I.S.J.; Schaik, I.N. van; Leger, J.M.; Bril, V.; Geloven, N. van; Hartung, H.P.; ... ; PRIMA Trial Investigators PATH 2019
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
Article / Letter to editor
metadata only
Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial
Walgaard, C.; Jacobs, B.C.; Lingsma, H.F.; Steyerberg, E.W.; Cornblath, D.R.; Doorn, P.A. van; Dutch GBS Study Grp 2018
Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial
Article / Letter to editor
open access
2019-09-24T00:00:00Z; 2019-09-24T00:00:00Z; 2019-09-24T00:00:00Z
Pseudodominant inheritance pattern in a family with CMT2 caused by GDAP1 mutations
Paassen, B.W. van; Bronk, M.; Verhamme, C.; Ruissen, F. van; Baas, F.; Spaendonck-Zwarts, K.Y. van; Visser, M. de 2017
Pseudodominant inheritance pattern in a family with CMT2 caused by GDAP1 mutations
Article / Letter to editor
metadata only
INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR RESTABILIZATION TREATMENT AFTER IVIG WITHDRAWAL IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP). RESULTS FROM THE PRE-RANDOMIZATION PHASE OF THE PATH STUDY
Mielke, O.; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; ... ; PATH Study Grp 2017
INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR RESTABILIZATION TREATMENT AFTER IVIG WITHDRAWAL IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP). RESULTS FROM THE PRE-RANDOMIZATION PHASE OF THE PATH STUDY
Article / Letter to editor
metadata only
SUBCUTANEOUS IMMUNOGLOBULIN FOR MAINTENANCE TREATMENT IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP), A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL: THE PATH STUDY
Schaik, I.N. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; ... ; PATH Study Grp 2017
SUBCUTANEOUS IMMUNOGLOBULIN FOR MAINTENANCE TREATMENT IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP), A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL: THE PATH STUDY
Article / Letter to editor
metadata only
International Guillain-Barre Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome
Jacobs, B.C.; Berg, B. van den; Verboon, C.; Chavada, G.; Cornblath, D.R.; Gorson, K.C.; ... ; IGOS Consortium 2017
International Guillain-Barre Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome
Article / Letter to editor
metadata only
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF TWO DIFFERENT DOSES OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) FOR THE TREATMENT OF CIDP: IGG DEPENDENCY AND RESTABILIZATION PHASE
Schaik, I.N. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; ... ; PATH Study Grp 2016
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF TWO DIFFERENT DOSES OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) FOR THE TREATMENT OF CIDP: IGG DEPENDENCY AND RESTABILIZATION PHASE
Article / Letter to editor
metadata only